Docetaxel
-
- Category :
Intermediates/Pharmaceutical intermediates
- CAS NO : 114977-28-5
- EC NO :
- Molecular Formula : C43H53NO14
- Main Specifications : USP42
- Synonyms : docetaxel;N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol;Docetaxel Anhydrous;(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;(1beta,2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;Decetaxel anhydrous;BIND-014;Docetaxel.Anhydrous;
Package: 100 gram/bag; 500 gram/bag; It can also be packed according to the requirements
Uses : Docetaxel is used in the treatment of various cancers, including breast, lung, prostate, gastric, head and neck, and ovarian cancer. Clinical data have shown docetaxel to have cytotoxic activity against breast, colorectal, lung, ovarian, prostate, liver,
Molecular Structure: